Sotera Health Company
NMS: SHCLive Quote
📈 ZcoreAI Score
Our AI model analyzes Sotera Health Company's price action across multiple timeframes using regression channels and statistical scoring.
Get SHC Z-Score →About Sotera Health Company
Healthcare
Diagnostics & Research
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
📊 Fundamental Analysis
Sotera Health Company demonstrates a profit margin of 6.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported 4.6% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 15.4%, which suggests room for improvement in capital utilization.
At a current price of $15.36, SHC currently sits at the 54th percentile of its 52-week range (Range: $10.17 - $19.85).
💰 Valuation Insight
SHC trades at a 127.6% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$4.38B
Trailing P/E
56.89
Forward P/E
14.68
Beta (5Y)
1.88
52W High
$19.85
52W Low
$10.17
Avg Volume
2.52M
Day High
Day Low